[1]王建红,郭富强.支架内再狭窄的发病机制研究[J].介入放射学杂志,2008,(10):754.
　WANG Jianhong,GUO Fuqiang.Study on pathogenesis for in－stent restenosis[J].journal interventional radiology,2008,(10):754.
点击复制

支架内再狭窄的发病机制研究()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2008年10期
页码:
754
栏目:
综述
出版日期:
2008-10-15

文章信息/Info

Title:
Study on pathogenesis for in－stent restenosis
作者:
王建红; 郭富强
６１００７２成都四川省人民医院神经内科、泸州医学院联合培养研究生
Author(s):
WANG Jian－hong; GUO Fu－qiang．
Department of Neurology，Sichuan Provincial People’s Hospital，Chengdu６１００７２，China
关键词:
发病机制; 支架内再狭窄
分类号:
R７４３
文献标志码:
A
摘要:
介入术后支架内再狭窄是重要的尚未解决的临床问题。血管平滑肌细胞的增殖和迁移是血管成形术后再狭窄发生的关键因素。血管内炎症反应也可能起着重要作用。对再狭窄病因的研究有助于找到一些新的治疗方法。

参考文献/References:

［１］Sprague EA．In vivo cardiovascular assays for drug discovery：evolution of the drug－eluting stent ［J］．Curr Opin Investing Drugs，２００７，８：２１９－２２５．
［２］Philippe F，Dibie A，Larrazet F，et al．Durg eluting stents：from evidence based medicine to clinical practice［J］．Ann Cardiol Angiol，２００５，５４：２０１－２１１．
［３］Mauri L，Hsieh WH，Massaro JM，et al．Stent thrombosis in randomized clinical trials of drug－eluting stents［J］．N Engl J Med，２００７，３５６：１０２０－１０２９．
［４］Huang Y，Salu K，Wang L，et al．Use of a tacrolimus－eluting stent to inhibit neointimal hyperplasia in a porcine cornary model［J］．J Invasive Cardiol，２００５，１７：１４２－１４８．
［５］Guarda E，Fajuri A，Dulin J，et al．The collagen of the restenosis post angioplasty with stent ：Is its origin in intima adventitia［J］．Rev Med Chil，２００１，１２９：１２４１－１２４７．
［６］Sardella G，Mariani A，Alessandro M，et al．Early elevation of interleukin－１beta and interleukin－６levels after bare or drug－eluting stent implantation in pations with stable angina［J］．Thromb Res，２００６，１１７：６５９－６６４．
［７］Welt FG，Tso C，Edelman ER，et al．Leukocyte recruitment and expression of chemokines following different forms of vascular injury［J］．Vasc Med，２００３，８：１－７．
［８］Mazighi M，Pelle A，Gonzalez W，et al．IL－１０inhibits vascular smooth muscle cell activation in vitro and in vivo［J］．Am J Physiol Heart Circ Physiol，２００４，２８７：H８６６－８７１．
［９］Chandrasekar B，Mummidis S，Mahimainathan L，et al．Interleukin－１８－induced human coronary artery smooth muscle cell migration is dependent on NF－kappaB－and AP－１－mediated matrix metalloproteinase－９expression and is inhibited by atorvastatin［J］．J Biol Chem，２００６，２８１：１５０９９－１５１０９．
［１０］严凤娣，何胜虎．内皮祖细胞与支架内再狭窄［J］．心血管病学进展，２００７，２８：３９７－４００．
［１１］Lee CW，Lin CC，Lin MN，et al．TNF－alpha induces MMP－９expression via activation of Src ／EGFR，PDGFR／PI３K／Akt cascade and promotion of NFkappaB／p３００binding in human tracheal smooth muscle cells［J］．Am J Physiol Lung Cell Mol Physiol，２００７，２９２：L７９９－８１２．
［１２］Miller AM，McPhaden AR，Preston A，et al．TNFalpha increases the inflammatory response to vascular balloon injury without accelerating neointimal formation［J］．Atherosclerosis，２００５，１７９：５１－５９．
［１３］Shimizu N，Suzuki H，Wakabayashi K，et al．Expression of intercellular adhesion molecule－１and vascular cell adhesion molecule－１in the pig coronary artery injury model：comparison of plain old balloon angioplasty and stent implantation［J］．J Cardiol，２００４，４３：１３１－１３９．
［１４］Groenewegen HC，Van der Harst P，Roks AJ ，et al．Effects of angiotensin II and angiotensin II type１receptor blockade on neointimal formation after stent implantation［J］．Int J Cardiol，２００７４；［Epub ahead of print ］．
［１５］Langeveld B，van Gilst WH，Tio RA，et al．Angiotensin－（１－７）attenuates neointimal formation after stent implantation in the rat［J］．Hypertension，２００５，４５：１３８－１４１．
［１６］Karha J，Bavry AA，Rajagopal V，et al．Relation of C－reactive protein level and long－term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus－eluting stent ［J］．Am J Cardiol，２００６，９８：６１６－６１８．
［１７］Kim JY，Ko YG，Shim CY，et al．Comparison of effects of drug－eluting stents versus bare metal stents on plasma C－reactive protein levels［J］．Am J Cardiol，２００５，９６：１３８４－１３８８．
［１８］Gaspardone A，Versaci F，Tomai F，et al．C－Reactive protein，clinical outcome ，and restenosis rates after implantation of different drug－eluting stents［J］．Am J Cardiol，２００６，９７：１３１１－１３１６．
［１９］Resch ZT，Chen BK，Bale LK，et al．Pregnancy２associated p lasma protein A gene expression as a target of inflammatory cytokines［J］．Endocrinology，２００４，１４５：１１２４－１１２９．
［２０］Conover CA，Bale LK，Harrington SC，et al．Cytokine stimulation of pregnancy associated plasma protein A expression in human coronary artery smooth muscle cells：inhibition by resveratrol［J］．Am J Physiol Cell Physiol，２００６，２９０：C１８３－１８８．
［２１］Shimokawa H，Takeshita A．Rho－Kinase is an important therap－eutic target in cardiovascular medicine［J］．Arteioscler Thromb Vasc Biol，２００５，２５：１７６７－１７７５．
［２２］Guérin P，Sauzeau V，Rolli－Derkinderen M，et al．Stent implan－tation activates RhoA in human arteries：inhibitory effect of rapamycin［J］．J Vasc Res，２００５，４２：２１－２８．
［２３］Shiba Y，Takahashi M，Yoshioka T，et al．M－CSF accelerates neointimal formation in the early phase after vascular injury in mice：the critical role of the SDF－１－CXCR４system［J］．Arterio－scler Thromb Vasc Biol，２００７，２７：２８３－２８９．
［２４］Yoshioka T，Takahashi M，Shiba Y，et al．Granulocyte colony－stimulating factor（G－CSF）accelerates reendoth elialization and reduces neointimal formation after vascular injury in mice［J］．Cardiovasc Res，２００６，７０：６１－６９．
［２５］Kojoglanian SA，Jorgensen MB，Wolde－Tsadik G，et al．Res－tenosis in Intervened Coronaries with Hyperhomo－cysteinemia（RICH）［J］．Am Heart J，２００３，１４６：１０７７－１０８１．
［２６］Bond M，Sala－Newby GB，Wu YJ ，et al．Biphasic effect of p２１Cip１on smooth muscle cell proliferation：role of PI ３－kinase and Skp２－mediated degradation［J］．Cardiovasc Res，２００６，６９：１９８－２０６．

相似文献/References:

[1]刘小希,邹 文,孟刘坤,等.急性冠状动脉综合征患者PCI术后受体相互作用蛋白激酶1表达及其与支架内再狭窄的关系 [J].介入放射学杂志,2021,30(05):438.
　LIU Xiaoxi,ZOU Wen,MENG Liukun,et al.The expression level of receptor-interacting protein kinase 1 in patients with acute coronary syndrome after PCI and its relationship with in-stent restenosis[J].journal interventional radiology,2021,30(10):438.
[2]王 辉,苏志向,谷涌泉.准分子激光斑块消蚀术联合药物涂层球囊治疗股腘动脉支架内再狭窄研究进展[J].介入放射学杂志,2022,31(05):507.
　WANG Hui,SU Zhixiang,GU Yongquan..Latest progress in excimer laser atherectomy combined with drug-coated balloon for in-stent restenosis of femoropopliteal artery [J].journal interventional radiology,2022,31(10):507.
[3]张 克,杨 涛,郝 斌.下肢动脉硬化闭塞症患者支架植入术后血清miR- 140- 5p与1年内支架内再狭窄相关性研究[J].介入放射学杂志,2022,31(06):555.
　ZHANG Ke,YANG Tao,HAO Bin..Correlation between serum microRNA-140-5p level and in-stent restenosis occurring within one year after interventional treatment in patients with lower extremity atherosclerotic occlusive disease[J].journal interventional radiology,2022,31(10):555.
[4]梁广财,黄 珊,施 磊,等.颈动脉支架内再狭窄研究进展[J].介入放射学杂志,2023,32(04):396.
　LIANG Guangcai,HUANG Shan,SHI Lei,et al.Research progress in carotid artery in-stent restenosis[J].journal interventional radiology,2023,32(10):396.
[5]梅峻豪,余海洋,秦立昊,等.孤立性肠系膜上动脉夹层发病机制研究[J].介入放射学杂志,2023,32(03):298.
　MEI Junhao,YU Haiyang,QIN Lihao,et al.Study on the pathogenesis of isolated superior mesenteric artery dissection[J].journal interventional radiology,2023,32(10):298.
[6]龚宇,于淼,田甜,等.高分辨率磁共振血管壁成像评估大脑中动脉狭窄斑块特征与支架内再狭窄的相关性[J].介入放射学杂志,2024,33(12):1282.
　GONG Yu,YU Miao,TIAN Tian,et al.High-resolution magnetic resonance angiography for assessing the correlation between plaque characteristics of middle cerebral artery stenosis and in-stent restenosis[J].journal interventional radiology,2024,33(10):1282.

备注/Memo

备注/Memo:
收稿日期：２００８－０１－１０
更新日期/Last Update: 2008-10-15